Search

everythinglearnresearchcommunity

for

Search:↓

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Androgenetic alopecia may indicate higher risk for certain diseases and mental health issues.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Six new risk spots for early hair loss were found, which also link to Parkinson's disease and lower fertility. Two genes, FOXA2 and HDAC4, could be new treatment targets. Hair loss might also be connected to heart disease, metabolic syndrome, and prostate cancer.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Balding and low testosterone increase risk of urinary stones.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Mutations in certain receptors can cause diseases and offer new treatment options.

Male hormones may make COVID-19 worse, while substances that block these hormones could lessen symptoms.

Continued research and awareness are needed to improve treatments for androgen-dependent diseases.

Certain drugs that block specific enzymes can help treat prostate diseases.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

Increased free testosterone can lead to stronger bones and less body fat but also higher risks of prostate cancer, hair loss, spine issues, and high blood pressure.

Piper cubeba and Aquilaria sinensis may help prevent or treat prostate issues by balancing hormones.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Feeling younger can improve health and extend life.